nodes	percent_of_prediction	percent_of_DWPC	metapath
Entacapone—COMT—Dopamine metabolism—TYR—melanoma	0.0427	0.231	CbGpPWpGaD
Entacapone—UGT1A9—Glucuronidation—UGT2B10—melanoma	0.0148	0.0801	CbGpPWpGaD
Entacapone—UGT1A9—Glucuronidation—UGT2B10—melanoma	0.012	0.0649	CbGpPWpGaD
Entacapone—COMT—Phase II conjugation—UGT2B10—melanoma	0.00754	0.0408	CbGpPWpGaD
Entacapone—COMT—Estrogen metabolism—CYP1B1—melanoma	0.00753	0.0408	CbGpPWpGaD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—ARNT—melanoma	0.00554	0.03	CbGpPWpGaD
Entacapone—UGT1A9—Phase II conjugation—UGT2B10—melanoma	0.00452	0.0245	CbGpPWpGaD
Entacapone—UGT1A9—Estrogen metabolism—CYP1B1—melanoma	0.00451	0.0244	CbGpPWpGaD
Entacapone—COMT—Biological oxidations—UGT2B10—melanoma	0.00441	0.0239	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—SLC39A12—melanoma	0.00435	0.0235	CbGpPWpGaD
Entacapone—UGT1A9—Irinotecan Pathway—APC—melanoma	0.00327	0.0177	CbGpPWpGaD
Entacapone—COMT—Metapathway biotransformation—AKR1B10—melanoma	0.0028	0.0152	CbGpPWpGaD
Entacapone—UGT1A9—Biological oxidations—UGT2B10—melanoma	0.00264	0.0143	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—SLC6A11—melanoma	0.00259	0.014	CbGpPWpGaD
Entacapone—UGT1A9—Constitutive Androstane Receptor Pathway—ABCB1—melanoma	0.00234	0.0127	CbGpPWpGaD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—CYP1B1—melanoma	0.00213	0.0115	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—EPHA2—melanoma	0.00212	0.0115	CbGpPWpGaD
Entacapone—UGT1A9—PPAR Alpha Pathway—CDK4—melanoma	0.00212	0.0115	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—SLC6A11—melanoma	0.002	0.0108	CbGpPWpGaD
Entacapone—COMT—Neuronal System—SLC6A11—melanoma	0.00199	0.0107	CbGpPWpGaD
Entacapone—Haemoglobin—Temozolomide—melanoma	0.00189	0.00232	CcSEcCtD
Entacapone—Hepatitis—Temozolomide—melanoma	0.00188	0.00231	CcSEcCtD
Entacapone—Haemorrhage—Temozolomide—melanoma	0.00188	0.00231	CcSEcCtD
Entacapone—Asthenia—Vemurafenib—melanoma	0.00188	0.0023	CcSEcCtD
Entacapone—Visual impairment—Carmustine—melanoma	0.00188	0.0023	CcSEcCtD
Entacapone—Hallucination—Temozolomide—melanoma	0.00187	0.0023	CcSEcCtD
Entacapone—Hypoaesthesia—Temozolomide—melanoma	0.00187	0.0023	CcSEcCtD
Entacapone—Pharyngitis—Temozolomide—melanoma	0.00187	0.00229	CcSEcCtD
Entacapone—Urinary tract disorder—Temozolomide—melanoma	0.00186	0.00228	CcSEcCtD
Entacapone—Pruritus—Vemurafenib—melanoma	0.00185	0.00227	CcSEcCtD
Entacapone—Urethral disorder—Temozolomide—melanoma	0.00185	0.00226	CcSEcCtD
Entacapone—Alopecia—Dactinomycin—melanoma	0.00184	0.00226	CcSEcCtD
Entacapone—Eye disorder—Carmustine—melanoma	0.00182	0.00223	CcSEcCtD
Entacapone—Visual impairment—Temozolomide—melanoma	0.00181	0.00223	CcSEcCtD
Entacapone—Gastrointestinal haemorrhage—Docetaxel—melanoma	0.00181	0.00222	CcSEcCtD
Entacapone—Pain in extremity—Docetaxel—melanoma	0.00181	0.00222	CcSEcCtD
Entacapone—Flushing—Carmustine—melanoma	0.00181	0.00222	CcSEcCtD
Entacapone—Ill-defined disorder—Bleomycin—melanoma	0.0018	0.00221	CcSEcCtD
Entacapone—Diarrhoea—Vemurafenib—melanoma	0.00179	0.0022	CcSEcCtD
Entacapone—Erythema multiforme—Temozolomide—melanoma	0.00178	0.00218	CcSEcCtD
Entacapone—Eye disorder—Temozolomide—melanoma	0.00176	0.00216	CcSEcCtD
Entacapone—Malaise—Bleomycin—melanoma	0.00175	0.00215	CcSEcCtD
Entacapone—Flushing—Temozolomide—melanoma	0.00175	0.00214	CcSEcCtD
Entacapone—Cardiac disorder—Temozolomide—melanoma	0.00175	0.00214	CcSEcCtD
Entacapone—Leukopenia—Bleomycin—melanoma	0.00174	0.00213	CcSEcCtD
Entacapone—Dizziness—Vemurafenib—melanoma	0.00173	0.00212	CcSEcCtD
Entacapone—Alopecia—Carmustine—melanoma	0.00172	0.00211	CcSEcCtD
Entacapone—Mental disorder—Carmustine—melanoma	0.00171	0.00209	CcSEcCtD
Entacapone—Ataxia—Docetaxel—melanoma	0.0017	0.00209	CcSEcCtD
Entacapone—Malnutrition—Carmustine—melanoma	0.0017	0.00208	CcSEcCtD
Entacapone—Cough—Bleomycin—melanoma	0.0017	0.00208	CcSEcCtD
Entacapone—Ill-defined disorder—Dactinomycin—melanoma	0.00168	0.00206	CcSEcCtD
Entacapone—UGT1A9—Metapathway biotransformation—AKR1B10—melanoma	0.00168	0.0091	CbGpPWpGaD
Entacapone—Vomiting—Vemurafenib—melanoma	0.00166	0.00204	CcSEcCtD
Entacapone—Alopecia—Temozolomide—melanoma	0.00166	0.00204	CcSEcCtD
Entacapone—Chest pain—Bleomycin—melanoma	0.00165	0.00203	CcSEcCtD
Entacapone—Myalgia—Bleomycin—melanoma	0.00165	0.00203	CcSEcCtD
Entacapone—Orthostatic hypotension—Docetaxel—melanoma	0.00165	0.00203	CcSEcCtD
Entacapone—Rash—Vemurafenib—melanoma	0.00165	0.00202	CcSEcCtD
Entacapone—Mental disorder—Temozolomide—melanoma	0.00165	0.00202	CcSEcCtD
Entacapone—Dermatitis—Vemurafenib—melanoma	0.00165	0.00202	CcSEcCtD
Entacapone—Back pain—Carmustine—melanoma	0.00164	0.00201	CcSEcCtD
Entacapone—Headache—Vemurafenib—melanoma	0.00164	0.00201	CcSEcCtD
Entacapone—Malnutrition—Temozolomide—melanoma	0.00164	0.00201	CcSEcCtD
Entacapone—Discomfort—Bleomycin—melanoma	0.00163	0.002	CcSEcCtD
Entacapone—Malaise—Dactinomycin—melanoma	0.00163	0.002	CcSEcCtD
Entacapone—Toxic epidermal necrolysis—Docetaxel—melanoma	0.00163	0.002	CcSEcCtD
Entacapone—Cramp muscle—Docetaxel—melanoma	0.00163	0.002	CcSEcCtD
Entacapone—Leukopenia—Dactinomycin—melanoma	0.00162	0.00199	CcSEcCtD
Entacapone—Dysgeusia—Temozolomide—melanoma	0.0016	0.00197	CcSEcCtD
Entacapone—Confusional state—Bleomycin—melanoma	0.0016	0.00196	CcSEcCtD
Entacapone—Vision blurred—Carmustine—melanoma	0.0016	0.00196	CcSEcCtD
Entacapone—Tremor—Carmustine—melanoma	0.00159	0.00195	CcSEcCtD
Entacapone—Oedema—Bleomycin—melanoma	0.00159	0.00194	CcSEcCtD
Entacapone—Back pain—Temozolomide—melanoma	0.00159	0.00194	CcSEcCtD
Entacapone—COMT—Transmission across Chemical Synapses—GRIN2A—melanoma	0.00158	0.00857	CbGpPWpGaD
Entacapone—Dysphagia—Docetaxel—melanoma	0.00156	0.00192	CcSEcCtD
Entacapone—Agitation—Carmustine—melanoma	0.00156	0.00191	CcSEcCtD
Entacapone—Nausea—Vemurafenib—melanoma	0.00155	0.00191	CcSEcCtD
Entacapone—Thrombocytopenia—Bleomycin—melanoma	0.00155	0.0019	CcSEcCtD
Entacapone—Vision blurred—Temozolomide—melanoma	0.00154	0.00189	CcSEcCtD
Entacapone—Myalgia—Dactinomycin—melanoma	0.00154	0.00189	CcSEcCtD
Entacapone—Tremor—Temozolomide—melanoma	0.00154	0.00188	CcSEcCtD
Entacapone—Discomfort—Dactinomycin—melanoma	0.00152	0.00187	CcSEcCtD
Entacapone—Angina pectoris—Docetaxel—melanoma	0.00152	0.00187	CcSEcCtD
Entacapone—Ill-defined disorder—Temozolomide—melanoma	0.00152	0.00186	CcSEcCtD
Entacapone—Leukopenia—Carmustine—melanoma	0.00152	0.00186	CcSEcCtD
Entacapone—Anorexia—Bleomycin—melanoma	0.00151	0.00185	CcSEcCtD
Entacapone—Agitation—Temozolomide—melanoma	0.00151	0.00185	CcSEcCtD
Entacapone—Angioedema—Temozolomide—melanoma	0.0015	0.00184	CcSEcCtD
Entacapone—Hypotension—Bleomycin—melanoma	0.00148	0.00182	CcSEcCtD
Entacapone—Oedema—Dactinomycin—melanoma	0.00148	0.00181	CcSEcCtD
Entacapone—Malaise—Temozolomide—melanoma	0.00148	0.00181	CcSEcCtD
Entacapone—Vertigo—Temozolomide—melanoma	0.00147	0.00181	CcSEcCtD
Entacapone—COMT—Biological oxidations—CYP17A1—melanoma	0.00147	0.00796	CbGpPWpGaD
Entacapone—Convulsion—Carmustine—melanoma	0.00147	0.0018	CcSEcCtD
Entacapone—Leukopenia—Temozolomide—melanoma	0.00147	0.0018	CcSEcCtD
Entacapone—Hypertension—Carmustine—melanoma	0.00146	0.0018	CcSEcCtD
Entacapone—COMT—Metapathway biotransformation—CYP17A1—melanoma	0.00145	0.00785	CbGpPWpGaD
Entacapone—Palpitations—Temozolomide—melanoma	0.00145	0.00178	CcSEcCtD
Entacapone—Thrombocytopenia—Dactinomycin—melanoma	0.00145	0.00178	CcSEcCtD
Entacapone—Musculoskeletal discomfort—Bleomycin—melanoma	0.00144	0.00177	CcSEcCtD
Entacapone—Chest pain—Carmustine—melanoma	0.00144	0.00177	CcSEcCtD
Entacapone—Myalgia—Carmustine—melanoma	0.00144	0.00177	CcSEcCtD
Entacapone—Anxiety—Carmustine—melanoma	0.00144	0.00176	CcSEcCtD
Entacapone—Cough—Temozolomide—melanoma	0.00143	0.00175	CcSEcCtD
Entacapone—Paraesthesia—Bleomycin—melanoma	0.00142	0.00175	CcSEcCtD
Entacapone—Weight increased—Docetaxel—melanoma	0.00142	0.00175	CcSEcCtD
Entacapone—Convulsion—Temozolomide—melanoma	0.00142	0.00174	CcSEcCtD
Entacapone—Weight decreased—Docetaxel—melanoma	0.00142	0.00174	CcSEcCtD
Entacapone—Hypertension—Temozolomide—melanoma	0.00141	0.00174	CcSEcCtD
Entacapone—Dyspnoea—Bleomycin—melanoma	0.00141	0.00173	CcSEcCtD
Entacapone—Anorexia—Dactinomycin—melanoma	0.00141	0.00173	CcSEcCtD
Entacapone—Pneumonia—Docetaxel—melanoma	0.0014	0.00172	CcSEcCtD
Entacapone—Confusional state—Carmustine—melanoma	0.0014	0.00171	CcSEcCtD
Entacapone—Myalgia—Temozolomide—melanoma	0.0014	0.00171	CcSEcCtD
Entacapone—Anxiety—Temozolomide—melanoma	0.00139	0.00171	CcSEcCtD
Entacapone—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.00139	0.0017	CcSEcCtD
Entacapone—Oedema—Carmustine—melanoma	0.00138	0.0017	CcSEcCtD
Entacapone—Discomfort—Temozolomide—melanoma	0.00138	0.00169	CcSEcCtD
Entacapone—Decreased appetite—Bleomycin—melanoma	0.00138	0.00169	CcSEcCtD
Entacapone—Acute coronary syndrome—Docetaxel—melanoma	0.00137	0.00169	CcSEcCtD
Entacapone—UGT1A9—PPAR Alpha Pathway—CCND1—melanoma	0.00137	0.00741	CbGpPWpGaD
Entacapone—Myocardial infarction—Docetaxel—melanoma	0.00137	0.00168	CcSEcCtD
Entacapone—Neuropathy peripheral—Docetaxel—melanoma	0.00137	0.00168	CcSEcCtD
Entacapone—Dry mouth—Temozolomide—melanoma	0.00136	0.00167	CcSEcCtD
Entacapone—Pain—Bleomycin—melanoma	0.00136	0.00166	CcSEcCtD
Entacapone—Conjunctivitis—Docetaxel—melanoma	0.00136	0.00166	CcSEcCtD
Entacapone—Thrombocytopenia—Carmustine—melanoma	0.00136	0.00166	CcSEcCtD
Entacapone—Confusional state—Temozolomide—melanoma	0.00135	0.00165	CcSEcCtD
Entacapone—Musculoskeletal discomfort—Dactinomycin—melanoma	0.00135	0.00165	CcSEcCtD
Entacapone—Oedema—Temozolomide—melanoma	0.00134	0.00164	CcSEcCtD
Entacapone—Anorexia—Carmustine—melanoma	0.00132	0.00162	CcSEcCtD
Entacapone—Hepatobiliary disease—Docetaxel—melanoma	0.00132	0.00162	CcSEcCtD
Entacapone—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—GPAM—melanoma	0.00132	0.00714	CbGpPWpGaD
Entacapone—Epistaxis—Docetaxel—melanoma	0.00132	0.00161	CcSEcCtD
Entacapone—Nervous system disorder—Temozolomide—melanoma	0.00131	0.00161	CcSEcCtD
Entacapone—Thrombocytopenia—Temozolomide—melanoma	0.00131	0.00161	CcSEcCtD
Entacapone—Feeling abnormal—Bleomycin—melanoma	0.00131	0.0016	CcSEcCtD
Entacapone—Agranulocytosis—Docetaxel—melanoma	0.0013	0.0016	CcSEcCtD
Entacapone—Skin disorder—Temozolomide—melanoma	0.0013	0.00159	CcSEcCtD
Entacapone—Hypotension—Carmustine—melanoma	0.00129	0.00159	CcSEcCtD
Entacapone—Hyperhidrosis—Temozolomide—melanoma	0.00129	0.00159	CcSEcCtD
Entacapone—Decreased appetite—Dactinomycin—melanoma	0.00129	0.00158	CcSEcCtD
Entacapone—Fatigue—Dactinomycin—melanoma	0.00127	0.00156	CcSEcCtD
Entacapone—Anorexia—Temozolomide—melanoma	0.00127	0.00156	CcSEcCtD
Entacapone—Pain—Dactinomycin—melanoma	0.00126	0.00155	CcSEcCtD
Entacapone—Musculoskeletal discomfort—Carmustine—melanoma	0.00126	0.00155	CcSEcCtD
Entacapone—Urticaria—Bleomycin—melanoma	0.00126	0.00154	CcSEcCtD
Entacapone—Haemoglobin—Docetaxel—melanoma	0.00126	0.00154	CcSEcCtD
Entacapone—Body temperature increased—Bleomycin—melanoma	0.00125	0.00154	CcSEcCtD
Entacapone—Haemorrhage—Docetaxel—melanoma	0.00125	0.00154	CcSEcCtD
Entacapone—Hepatitis—Docetaxel—melanoma	0.00125	0.00154	CcSEcCtD
Entacapone—Insomnia—Carmustine—melanoma	0.00125	0.00154	CcSEcCtD
Entacapone—Hypoaesthesia—Docetaxel—melanoma	0.00125	0.00153	CcSEcCtD
Entacapone—Paraesthesia—Carmustine—melanoma	0.00124	0.00152	CcSEcCtD
Entacapone—Pharyngitis—Docetaxel—melanoma	0.00124	0.00152	CcSEcCtD
Entacapone—COMT—Biological oxidations—CYP1B1—melanoma	0.00124	0.0067	CbGpPWpGaD
Entacapone—Urinary tract disorder—Docetaxel—melanoma	0.00124	0.00152	CcSEcCtD
Entacapone—Dyspnoea—Carmustine—melanoma	0.00123	0.00151	CcSEcCtD
Entacapone—Somnolence—Carmustine—melanoma	0.00123	0.00151	CcSEcCtD
Entacapone—Urethral disorder—Docetaxel—melanoma	0.00123	0.00151	CcSEcCtD
Entacapone—COMT—Metapathway biotransformation—CYP1B1—melanoma	0.00122	0.00661	CbGpPWpGaD
Entacapone—Feeling abnormal—Dactinomycin—melanoma	0.00122	0.00149	CcSEcCtD
Entacapone—Musculoskeletal discomfort—Temozolomide—melanoma	0.00122	0.00149	CcSEcCtD
Entacapone—COMT—Neuronal System—GRIN2A—melanoma	0.00121	0.00657	CbGpPWpGaD
Entacapone—Insomnia—Temozolomide—melanoma	0.00121	0.00148	CcSEcCtD
Entacapone—Gastrointestinal pain—Dactinomycin—melanoma	0.00121	0.00148	CcSEcCtD
Entacapone—Visual impairment—Docetaxel—melanoma	0.00121	0.00148	CcSEcCtD
Entacapone—Decreased appetite—Carmustine—melanoma	0.0012	0.00148	CcSEcCtD
Entacapone—Paraesthesia—Temozolomide—melanoma	0.0012	0.00147	CcSEcCtD
Entacapone—Gastrointestinal disorder—Carmustine—melanoma	0.00119	0.00147	CcSEcCtD
Entacapone—Dyspnoea—Temozolomide—melanoma	0.00119	0.00146	CcSEcCtD
Entacapone—Somnolence—Temozolomide—melanoma	0.00119	0.00146	CcSEcCtD
Entacapone—Erythema multiforme—Docetaxel—melanoma	0.00118	0.00145	CcSEcCtD
Entacapone—Constipation—Carmustine—melanoma	0.00118	0.00145	CcSEcCtD
Entacapone—Pain—Carmustine—melanoma	0.00118	0.00145	CcSEcCtD
Entacapone—Dyspepsia—Temozolomide—melanoma	0.00118	0.00144	CcSEcCtD
Entacapone—Eye disorder—Docetaxel—melanoma	0.00117	0.00143	CcSEcCtD
Entacapone—Abdominal pain—Dactinomycin—melanoma	0.00117	0.00143	CcSEcCtD
Entacapone—Body temperature increased—Dactinomycin—melanoma	0.00117	0.00143	CcSEcCtD
Entacapone—Hypersensitivity—Bleomycin—melanoma	0.00117	0.00143	CcSEcCtD
Entacapone—Decreased appetite—Temozolomide—melanoma	0.00116	0.00143	CcSEcCtD
Entacapone—Flushing—Docetaxel—melanoma	0.00116	0.00143	CcSEcCtD
Entacapone—Cardiac disorder—Docetaxel—melanoma	0.00116	0.00143	CcSEcCtD
Entacapone—Gastrointestinal disorder—Temozolomide—melanoma	0.00115	0.00142	CcSEcCtD
Entacapone—Fatigue—Temozolomide—melanoma	0.00115	0.00141	CcSEcCtD
Entacapone—Constipation—Temozolomide—melanoma	0.00114	0.0014	CcSEcCtD
Entacapone—Pain—Temozolomide—melanoma	0.00114	0.0014	CcSEcCtD
Entacapone—Feeling abnormal—Carmustine—melanoma	0.00114	0.0014	CcSEcCtD
Entacapone—Asthenia—Bleomycin—melanoma	0.00114	0.0014	CcSEcCtD
Entacapone—Gastrointestinal pain—Carmustine—melanoma	0.00113	0.00139	CcSEcCtD
Entacapone—Pruritus—Bleomycin—melanoma	0.00112	0.00138	CcSEcCtD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—ACER3—melanoma	0.00111	0.00601	CbGpPWpGaD
Entacapone—Alopecia—Docetaxel—melanoma	0.00111	0.00136	CcSEcCtD
Entacapone—Feeling abnormal—Temozolomide—melanoma	0.0011	0.00135	CcSEcCtD
Entacapone—UGT1A9—PPAR Alpha Pathway—MYC—melanoma	0.0011	0.00595	CbGpPWpGaD
Entacapone—Mental disorder—Docetaxel—melanoma	0.0011	0.00135	CcSEcCtD
Entacapone—Abdominal pain—Carmustine—melanoma	0.00109	0.00134	CcSEcCtD
Entacapone—Body temperature increased—Carmustine—melanoma	0.00109	0.00134	CcSEcCtD
Entacapone—Gastrointestinal pain—Temozolomide—melanoma	0.00109	0.00134	CcSEcCtD
Entacapone—Malnutrition—Docetaxel—melanoma	0.00109	0.00134	CcSEcCtD
Entacapone—Hypersensitivity—Dactinomycin—melanoma	0.00109	0.00134	CcSEcCtD
Entacapone—Dysgeusia—Docetaxel—melanoma	0.00107	0.00131	CcSEcCtD
Entacapone—Urticaria—Temozolomide—melanoma	0.00106	0.0013	CcSEcCtD
Entacapone—Asthenia—Dactinomycin—melanoma	0.00106	0.0013	CcSEcCtD
Entacapone—Abdominal pain—Temozolomide—melanoma	0.00106	0.0013	CcSEcCtD
Entacapone—Body temperature increased—Temozolomide—melanoma	0.00106	0.0013	CcSEcCtD
Entacapone—Back pain—Docetaxel—melanoma	0.00105	0.00129	CcSEcCtD
Entacapone—Muscle spasms—Docetaxel—melanoma	0.00105	0.00129	CcSEcCtD
Entacapone—Hypersensitivity—Carmustine—melanoma	0.00102	0.00125	CcSEcCtD
Entacapone—Diarrhoea—Dactinomycin—melanoma	0.00101	0.00124	CcSEcCtD
Entacapone—Vomiting—Bleomycin—melanoma	0.00101	0.00124	CcSEcCtD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IFNG—melanoma	0.001	0.00542	CbGpPWpGaD
Entacapone—Rash—Bleomycin—melanoma	0.001	0.00123	CcSEcCtD
Entacapone—Dermatitis—Bleomycin—melanoma	0.000999	0.00123	CcSEcCtD
Entacapone—Asthenia—Carmustine—melanoma	0.000993	0.00122	CcSEcCtD
Entacapone—Hypersensitivity—Temozolomide—melanoma	0.000985	0.00121	CcSEcCtD
Entacapone—Syncope—Docetaxel—melanoma	0.000977	0.0012	CcSEcCtD
Entacapone—Leukopenia—Docetaxel—melanoma	0.000975	0.0012	CcSEcCtD
Entacapone—Palpitations—Docetaxel—melanoma	0.000963	0.00118	CcSEcCtD
Entacapone—Asthenia—Temozolomide—melanoma	0.00096	0.00118	CcSEcCtD
Entacapone—Loss of consciousness—Docetaxel—melanoma	0.000958	0.00117	CcSEcCtD
Entacapone—Cough—Docetaxel—melanoma	0.000951	0.00117	CcSEcCtD
Entacapone—Diarrhoea—Carmustine—melanoma	0.000947	0.00116	CcSEcCtD
Entacapone—Pruritus—Temozolomide—melanoma	0.000946	0.00116	CcSEcCtD
Entacapone—Convulsion—Docetaxel—melanoma	0.000944	0.00116	CcSEcCtD
Entacapone—Nausea—Bleomycin—melanoma	0.000942	0.00116	CcSEcCtD
Entacapone—Hypertension—Docetaxel—melanoma	0.000941	0.00115	CcSEcCtD
Entacapone—Vomiting—Dactinomycin—melanoma	0.00094	0.00115	CcSEcCtD
Entacapone—Rash—Dactinomycin—melanoma	0.000932	0.00114	CcSEcCtD
Entacapone—Chest pain—Docetaxel—melanoma	0.000928	0.00114	CcSEcCtD
Entacapone—Myalgia—Docetaxel—melanoma	0.000928	0.00114	CcSEcCtD
Entacapone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000921	0.00113	CcSEcCtD
Entacapone—Dizziness—Carmustine—melanoma	0.000915	0.00112	CcSEcCtD
Entacapone—Diarrhoea—Temozolomide—melanoma	0.000915	0.00112	CcSEcCtD
Entacapone—UGT1A9—NRF2 pathway—SLC5A5—melanoma	0.000913	0.00494	CbGpPWpGaD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—CDKN1B—melanoma	0.000909	0.00492	CbGpPWpGaD
Entacapone—Dry mouth—Docetaxel—melanoma	0.000907	0.00111	CcSEcCtD
Entacapone—Confusional state—Docetaxel—melanoma	0.000897	0.0011	CcSEcCtD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL2—melanoma	0.00089	0.00482	CbGpPWpGaD
Entacapone—Oedema—Docetaxel—melanoma	0.000889	0.00109	CcSEcCtD
Entacapone—Dizziness—Temozolomide—melanoma	0.000884	0.00108	CcSEcCtD
Entacapone—UGT1A9—Biological oxidations—CYP17A1—melanoma	0.000881	0.00477	CbGpPWpGaD
Entacapone—Vomiting—Carmustine—melanoma	0.00088	0.00108	CcSEcCtD
Entacapone—Nausea—Dactinomycin—melanoma	0.000878	0.00108	CcSEcCtD
Entacapone—Shock—Docetaxel—melanoma	0.000875	0.00107	CcSEcCtD
Entacapone—Rash—Carmustine—melanoma	0.000873	0.00107	CcSEcCtD
Entacapone—Nervous system disorder—Docetaxel—melanoma	0.000872	0.00107	CcSEcCtD
Entacapone—Dermatitis—Carmustine—melanoma	0.000872	0.00107	CcSEcCtD
Entacapone—Thrombocytopenia—Docetaxel—melanoma	0.000871	0.00107	CcSEcCtD
Entacapone—UGT1A9—Metapathway biotransformation—CYP17A1—melanoma	0.000869	0.0047	CbGpPWpGaD
Entacapone—Headache—Carmustine—melanoma	0.000867	0.00106	CcSEcCtD
Entacapone—Skin disorder—Docetaxel—melanoma	0.000864	0.00106	CcSEcCtD
Entacapone—Vomiting—Temozolomide—melanoma	0.00085	0.00104	CcSEcCtD
Entacapone—Anorexia—Docetaxel—melanoma	0.000848	0.00104	CcSEcCtD
Entacapone—Rash—Temozolomide—melanoma	0.000843	0.00103	CcSEcCtD
Entacapone—Dermatitis—Temozolomide—melanoma	0.000842	0.00103	CcSEcCtD
Entacapone—Headache—Temozolomide—melanoma	0.000838	0.00103	CcSEcCtD
Entacapone—COMT—Transmission across Chemical Synapses—PRKCA—melanoma	0.000831	0.0045	CbGpPWpGaD
Entacapone—Hypotension—Docetaxel—melanoma	0.000831	0.00102	CcSEcCtD
Entacapone—COMT—Metabolism—ACER3—melanoma	0.000825	0.00447	CbGpPWpGaD
Entacapone—Nausea—Carmustine—melanoma	0.000822	0.00101	CcSEcCtD
Entacapone—Musculoskeletal discomfort—Docetaxel—melanoma	0.00081	0.000994	CcSEcCtD
Entacapone—Insomnia—Docetaxel—melanoma	0.000804	0.000987	CcSEcCtD
Entacapone—Paraesthesia—Docetaxel—melanoma	0.000799	0.00098	CcSEcCtD
Entacapone—Nausea—Temozolomide—melanoma	0.000794	0.000974	CcSEcCtD
Entacapone—Dyspnoea—Docetaxel—melanoma	0.000793	0.000973	CcSEcCtD
Entacapone—Somnolence—Docetaxel—melanoma	0.000791	0.00097	CcSEcCtD
Entacapone—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—FASN—melanoma	0.000785	0.00425	CbGpPWpGaD
Entacapone—Dyspepsia—Docetaxel—melanoma	0.000783	0.00096	CcSEcCtD
Entacapone—Decreased appetite—Docetaxel—melanoma	0.000773	0.000948	CcSEcCtD
Entacapone—Gastrointestinal disorder—Docetaxel—melanoma	0.000768	0.000942	CcSEcCtD
Entacapone—Fatigue—Docetaxel—melanoma	0.000767	0.000941	CcSEcCtD
Entacapone—Pain—Docetaxel—melanoma	0.000761	0.000933	CcSEcCtD
Entacapone—Constipation—Docetaxel—melanoma	0.000761	0.000933	CcSEcCtD
Entacapone—COMT—Metabolism—UGT2B10—melanoma	0.000755	0.00409	CbGpPWpGaD
Entacapone—UGT1A9—Biological oxidations—CYP1B1—melanoma	0.000742	0.00402	CbGpPWpGaD
Entacapone—Feeling abnormal—Docetaxel—melanoma	0.000733	0.000899	CcSEcCtD
Entacapone—UGT1A9—Metapathway biotransformation—CYP1B1—melanoma	0.000731	0.00396	CbGpPWpGaD
Entacapone—Gastrointestinal pain—Docetaxel—melanoma	0.000727	0.000892	CcSEcCtD
Entacapone—Abdominal pain—Docetaxel—melanoma	0.000703	0.000862	CcSEcCtD
Entacapone—Body temperature increased—Docetaxel—melanoma	0.000703	0.000862	CcSEcCtD
Entacapone—COMT—Metabolism—HS3ST5—melanoma	0.000702	0.0038	CbGpPWpGaD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EGFR—melanoma	0.00068	0.00368	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—HGF—melanoma	0.000676	0.00366	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—PIP4K2A—melanoma	0.000673	0.00364	CbGpPWpGaD
Entacapone—Hypersensitivity—Docetaxel—melanoma	0.000655	0.000804	CcSEcCtD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—melanoma	0.000648	0.00351	CbGpPWpGaD
Entacapone—Asthenia—Docetaxel—melanoma	0.000638	0.000783	CcSEcCtD
Entacapone—COMT—Neuronal System—PRKCA—melanoma	0.000637	0.00345	CbGpPWpGaD
Entacapone—Pruritus—Docetaxel—melanoma	0.000629	0.000772	CcSEcCtD
Entacapone—COMT—Transmission across Chemical Synapses—BRAF—melanoma	0.000612	0.00331	CbGpPWpGaD
Entacapone—Diarrhoea—Docetaxel—melanoma	0.000609	0.000746	CcSEcCtD
Entacapone—UGT1A9—PPARA activates gene expression—PPARG—melanoma	0.000608	0.00329	CbGpPWpGaD
Entacapone—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—melanoma	0.000595	0.00322	CbGpPWpGaD
Entacapone—Dizziness—Docetaxel—melanoma	0.000588	0.000721	CcSEcCtD
Entacapone—Vomiting—Docetaxel—melanoma	0.000566	0.000694	CcSEcCtD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—CUBN—melanoma	0.000561	0.00304	CbGpPWpGaD
Entacapone—Rash—Docetaxel—melanoma	0.000561	0.000688	CcSEcCtD
Entacapone—Dermatitis—Docetaxel—melanoma	0.00056	0.000687	CcSEcCtD
Entacapone—Headache—Docetaxel—melanoma	0.000557	0.000683	CcSEcCtD
Entacapone—COMT—Metabolism—PLCB4—melanoma	0.000532	0.00288	CbGpPWpGaD
Entacapone—Nausea—Docetaxel—melanoma	0.000528	0.000648	CcSEcCtD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—GPAM—melanoma	0.000525	0.00284	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—MDM2—melanoma	0.000513	0.00278	CbGpPWpGaD
Entacapone—COMT—Metabolism—SLC6A11—melanoma	0.0005	0.00271	CbGpPWpGaD
Entacapone—COMT—Metabolism—PIP4K2A—melanoma	0.0005	0.00271	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—ACER3—melanoma	0.000494	0.00268	CbGpPWpGaD
Entacapone—COMT—Metabolism—MTAP—melanoma	0.000486	0.00263	CbGpPWpGaD
Entacapone—COMT—Neuronal System—BRAF—melanoma	0.000469	0.00254	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—UGT2B10—melanoma	0.000452	0.00245	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	0.000446	0.00242	CbGpPWpGaD
Entacapone—COMT—Metabolism—LUM—melanoma	0.000433	0.00235	CbGpPWpGaD
Entacapone—COMT—Metabolism—PHGDH—melanoma	0.000433	0.00235	CbGpPWpGaD
Entacapone—COMT—Metabolism—HPSE—melanoma	0.000425	0.0023	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—HS3ST5—melanoma	0.00042	0.00228	CbGpPWpGaD
Entacapone—COMT—Metabolism—CUBN—melanoma	0.000417	0.00226	CbGpPWpGaD
Entacapone—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—melanoma	0.00041	0.00222	CbGpPWpGaD
Entacapone—COMT—Metabolism—SDHD—melanoma	0.000403	0.00218	CbGpPWpGaD
Entacapone—COMT—Metabolism—CSPG4—melanoma	0.000403	0.00218	CbGpPWpGaD
Entacapone—COMT—Metabolism—BSG—melanoma	0.000403	0.00218	CbGpPWpGaD
Entacapone—COMT—Neuronal System—MDM2—melanoma	0.000393	0.00213	CbGpPWpGaD
Entacapone—COMT—Metabolism—GPAM—melanoma	0.00039	0.00211	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—MAPK1—melanoma	0.000351	0.0019	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	0.000338	0.00183	CbGpPWpGaD
Entacapone—COMT—Metabolism—PLA2G6—melanoma	0.000332	0.0018	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PLCB4—melanoma	0.000319	0.00172	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—FASN—melanoma	0.000313	0.00169	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—SLC6A11—melanoma	0.0003	0.00162	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PIP4K2A—melanoma	0.0003	0.00162	CbGpPWpGaD
Entacapone—COMT—Metabolism—VCAN—melanoma	0.000298	0.00161	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—MTAP—melanoma	0.000291	0.00158	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	0.000285	0.00154	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—HRAS—melanoma	0.000281	0.00152	CbGpPWpGaD
Entacapone—COMT—Neuronal System—MAPK1—melanoma	0.000269	0.00145	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—LUM—melanoma	0.00026	0.00141	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PHGDH—melanoma	0.00026	0.00141	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—HPSE—melanoma	0.000255	0.00138	CbGpPWpGaD
Entacapone—COMT—Metabolism—CYP17A1—melanoma	0.000251	0.00136	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CUBN—melanoma	0.00025	0.00135	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—SDHD—melanoma	0.000241	0.00131	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—BSG—melanoma	0.000241	0.00131	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CSPG4—melanoma	0.000241	0.00131	CbGpPWpGaD
Entacapone—COMT—Metabolism—GNA11—melanoma	0.000238	0.00129	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—GPAM—melanoma	0.000234	0.00127	CbGpPWpGaD
Entacapone—COMT—Metabolism—FASN—melanoma	0.000232	0.00126	CbGpPWpGaD
Entacapone—COMT—Metabolism—SLC5A5—melanoma	0.000229	0.00124	CbGpPWpGaD
Entacapone—COMT—Metabolism—GNAQ—melanoma	0.000221	0.0012	CbGpPWpGaD
Entacapone—COMT—Metabolism—CD44—melanoma	0.000221	0.0012	CbGpPWpGaD
Entacapone—COMT—Neuronal System—HRAS—melanoma	0.000216	0.00117	CbGpPWpGaD
Entacapone—COMT—Metabolism—CYP1B1—melanoma	0.000212	0.00115	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PLA2G6—melanoma	0.000199	0.00108	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—VCAN—melanoma	0.000179	0.000967	CbGpPWpGaD
Entacapone—COMT—Metabolism—ABCB1—melanoma	0.000174	0.000944	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	0.000169	0.000915	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—melanoma	0.000163	0.000883	CbGpPWpGaD
Entacapone—COMT—Metabolism—PRKCA—melanoma	0.00016	0.000869	CbGpPWpGaD
Entacapone—COMT—Metabolism—ERCC2—melanoma	0.000159	0.000861	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CYP17A1—melanoma	0.000151	0.000816	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	0.000149	0.000805	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—ALB—melanoma	0.000147	0.000794	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—GNA11—melanoma	0.000142	0.00077	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—FASN—melanoma	0.000139	0.000754	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—SLC5A5—melanoma	0.000137	0.000742	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—GNAQ—melanoma	0.000132	0.000716	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CD44—melanoma	0.000132	0.000716	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	0.00013	0.000701	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	0.000128	0.000695	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CYP1B1—melanoma	0.000127	0.000687	CbGpPWpGaD
Entacapone—COMT—Metabolism—PIK3CG—melanoma	0.000126	0.00068	CbGpPWpGaD
Entacapone—COMT—Metabolism—PPARG—melanoma	0.000121	0.000657	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—melanoma	0.000112	0.000606	CbGpPWpGaD
Entacapone—COMT—Metabolism—PIK3CD—melanoma	0.00011	0.000598	CbGpPWpGaD
Entacapone—COMT—Metabolism—ALB—melanoma	0.000109	0.00059	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—ABCB1—melanoma	0.000104	0.000565	CbGpPWpGaD
Entacapone—COMT—Metabolism—PIK3CB—melanoma	9.63e-05	0.000521	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PRKCA—melanoma	9.61e-05	0.00052	CbGpPWpGaD
Entacapone—COMT—Metabolism—PTGS2—melanoma	9.54e-05	0.000517	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—ERCC2—melanoma	9.53e-05	0.000516	CbGpPWpGaD
Entacapone—COMT—Metabolism—PTEN—melanoma	8.32e-05	0.00045	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	7.9e-05	0.000428	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PIK3CG—melanoma	7.53e-05	0.000408	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PPARG—melanoma	7.27e-05	0.000393	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PIK3CD—melanoma	6.62e-05	0.000358	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—ALB—melanoma	6.53e-05	0.000354	CbGpPWpGaD
Entacapone—COMT—Metabolism—PIK3CA—melanoma	5.87e-05	0.000318	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PIK3CB—melanoma	5.77e-05	0.000312	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PTGS2—melanoma	5.72e-05	0.000309	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PTEN—melanoma	4.98e-05	0.00027	CbGpPWpGaD
Entacapone—COMT—Metabolism—AKT1—melanoma	4.8e-05	0.00026	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PIK3CA—melanoma	3.52e-05	0.00019	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—AKT1—melanoma	2.87e-05	0.000156	CbGpPWpGaD
